Published in Healthcare Mergers, Acquisitions and Ventures Week, December 16th, 2006
The company expects to announce the results in late February 2007.
A total of 441 patients have been enrolled in Study 06, a randomized, double-blind, placebo-controlled trial, at 40 sites in the United States and 5 sites in Europe. The primary endpoint is the proportion of patients with at least a 50% improvement in the Brief Psychiatric Rating Scale Positive Symptom Subscale (BPRS PSS)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.